Comparison of the associations between office and home BP with placenta-mediated pregnancy complications: the BOSHI study
This prospective cohort study compared the associations between office blood pressure (OBP) and home blood pressure (HBP) measured before 20 weeks of gestation with the subsequent development of placenta-mediated pregnancy complications (PMPCs). A total of 975 pregnant women were included in the study. OBP and HBP were measured between 10 weeks 0 days and 19 weeks 6 days of gestation, using HBP values from the same gestational weeks as OBP. When both OBP and HBP were included simultaneously in a binary logistic regression model, per 1 standard deviation increase, the adjusted odds ratios (aORs) for office and home systolic blood pressure (SBP) were 1.16 (95% confidence interval [CI]: 0.95-1.42) and 1.68 (95% CI: 1.36-2.09), respectively. For diastolic blood pressure (DBP), the aORs were 1.36 (95% CI: 1.10-1.69) for office and 1.70 (95% CI: 1.37-2.12) for home measurements. The likelihood ratio test showed that adding home SBP to a model with office SBP improved model fit (P value < 0.0001), whereas adding office SBP to a model with home SBP did not (P value = 0.2). For DBP, adding either home or office values improved model fit (P value < 0.0001 and P value = 0.005, respectively). Home SBP was more strongly associated with PMPCs than office SBP. Although home DBP was not statistically stronger than office DBP, its effect estimate was higher. These findings support the added value of HBP monitoring during pregnancy for predicting PMPCs.
Authors
- Taku Obara (ORCID: https://orcid.org/0000-0002-3674-1674)
- Takahisa Murakami (ORCID: https://orcid.org/0000-0002-1405-8532)
- Seiya Izumi (ORCID: https://orcid.org/0009-0000-7683-0877)
- Hirotaka Hamada (ORCID: https://orcid.org/0000-0002-6397-5898)
- Hiroki Nobayashi (ORCID: https://orcid.org/0000-0002-1783-8024)
- Michihiro Satoh (ORCID: https://orcid.org/0000-0003-1688-1239)
- Masatoshi Saito
- Yohsuke Imai (ORCID: https://orcid.org/0000-0002-4856-3799)
- Takayoshi Ohkubo (ORCID: https://orcid.org/0000-0002-3283-8196)
- Hirohito Metoki (ORCID: https://orcid.org/0000-0002-1894-3328)
- Hasumi Tomita (ORCID: https://orcid.org/0000-0003-3942-8592)
- Noriyuki Iwama (ORCID: https://orcid.org/0000-0002-6808-0911)
- Mami Ishikuro (ORCID: https://orcid.org/0000-0002-2884-0023)
- Shinichi Kuriyama (ORCID: https://orcid.org/0000-0002-6445-0911)
- Kazuhiko Hoshi
Institutions
- Jikei University School of Medicine (JP)
- Suzuki (Japan) (JP)
- Tohoku University (JP)
- Tohoku University Hospital (JP)
- Tohoku Medical Megabank Organization (JP)
- Tohoku Medical and Pharmaceutical University Hospital (JP)
- Tohoku Medical and Pharmaceutical University (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Hypertension Research
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1038/s41440-025-02439-x
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Japan Agency for Medical Research and Development
- Daiichi-Sankyo
- Astellas Pharma
- Otsuka Pharmaceutical
- Pfizer Japan
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science
- Daiichi Sankyo Europe